Covidien (COV) publishes the final results of the pivotal trial for its Pipeline embolization...

|By:, SA News Editor

Covidien (COV) publishes the final results of the pivotal trial for its Pipeline embolization device for the treatment of patients with an unruptured large or giant wide-necked aneurysm in Radiology, the official peer-reviewed journal of the Radiological Society. Data from this trial led the FDA to approve the treatment in 2011. (PR)